Enzymotec Plunges Midday on Unimpressive Q1 Results

Today’s top gainers at midday are ExOne Co (NASDAQ:XONE), Criteo SA (ADR) (NASDAQ:CRTO) and Zulily Inc (NASDAQ:ZU). The losers are Enzymotec Ltd (NASDAQ:ENZY), Take-Two Interactive Software, Inc. (NASDAQ:TTWO) and URS Corp (NYSE:URS).

ExOne Jumps Ahead of Results Release

The share price of 3D printer manufacturer ExOne Co (NASDAQ:XONE) jumped +15.68% midday today, ahead of tomorrow’s results release. Investors seem more upbeat about the company’s prospects, though its price is still down -47.65% YTD. Daniel Loeb, David Einhorn and Boone Pickens all have stakes in XONE.

Up +12.23% is Criteo SA (ADR) (NASDAQ:CRTO), which seems to be recovering from its post-results dive. CRTO is a Tiger Global asset.

Another Tiger pick, Zulily Inc (NASDAQ:ZU), rounds out today’s list of gainers. Its price increased +7.88%, coming back from last week’s major drop. Its price is still down -16.73% this year.

Enzymotec Dives

John Paulson holding Enzymotec Ltd (NASDAQ:ENZY) is the biggest loser midday today. Its stock price plunged -27.66% – a clear sign that its Q1 results have not been received well by investors.

Two David Einhorn picks – URS Corp (NYSE:URS) and Take-Two Interactive Software, Inc. (NASDAQ:TTWO) – also had a tough start to the day. Both fell -7.76% after posting losses on their respective results releases.

For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)



About the Author

iBillionaire
iBillionaire provides access to the investment data and strategies of the world's most successful self-made billionaires. Mobile app available for iOS and Android. Maker of the iBillionaire Index (IBLN). More at www.iBillionaire.me.

Be the first to comment on "Enzymotec Plunges Midday on Unimpressive Q1 Results"

Leave a comment

Your email address will not be published.